BRAY CAPITAL ADVISORS – AstraZeneca PLC Transaction History
BRAY CAPITAL ADVISORS portfolio value:
$466,000
portfolio value
BRAY CAPITAL ADVISORS quarter portfolio value change:
-17.00%
quarter
AstraZeneca PLC 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -96K | $54.84 | 8.5K | |
| Q2 2022 | share | 0.00% | 0 shares | -2K | $66.07 | 8.5K | |
| Q1 2022 | share | 0.00% | 0 shares | 69K | $66.34 | 8.5K | |
| Q4 2021 | share | 0.00% | 0 shares | -16K | $58.47 | 8.5K | |
| Q3 2021 | share | 0.00% | 0 shares | 2K | $60.06 | 8.5K | |
| Q2 2021 | share | 0.00% | 0 shares | 86K | $59.44 | 8.5K | |
| Q1 2021 | share | 0.00% | 0 shares | -2K | $49.34 | 8.5K | |
| Q4 2020 | share | 0.00% | 0 shares | -41K | $48.68 | 8.5K | |
| Q3 2020 | share | 0.00% | 0 shares | 16K | $53.37 | 8.5K | |
| Q2 2020 | share | 0.00% | 0 shares | 70K | $51.1 | 8.5K | |
| Q1 2020 | share | 0.00% | 0 shares | -44K | $43.15 | 8.5K | |
| Q4 2019 | share | Decrease | -10.53% | -1K shares | 1K | $47.17 | 8.5K |
| Q3 2019 | share | 0.00% | 0 shares | 31K | $42.17 | 9.5K | |
| Q2 2019 | share | 0.00% | 0 shares | 8K | $38.66 | 9.5K | |
| Q1 2019 | share | Decrease | -9.52% | -1K shares | -15K | $37.87 | 9.5K |
| Q4 2018 | share | 0.00% | 0 shares | -16K | $34.78 | 10.5K | |
| Q3 2018 | share | 0.00% | 0 shares | 46K | $36.23 | 10.5K | |
| Q2 2018 | share | 0.00% | 0 shares | 2K | $31.79 | 10.5K | |
| Q1 2018 | share | 0.00% | 0 shares | 3K | $31.66 | 10.5K | |
| Q4 2017 | share | 0.00% | 0 shares | 8K | $30.56 | 10.5K | |
| Q3 2017 | share | 0.00% | 0 shares | -2K | $29.84 | 10.5K | |
| Q2 2017 | share | Increase | 0.00% | 10.5K shares | 358K | $29.58 | 10.5K |
| Q1 2017 | share | Decrease | -1.87% | -200 shares | 35K | $27.02 | 10.5K |
| Q4 2016 | share | Increase | 0.00% | 10.7K shares | 292K | $22.97 | 10.7K |